Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Simcyp
Sheffield, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Simcyp provides commercial physiologically-based pharmacokinetic (PBPK) and related modeling software used across discovery and all stages of clinical development to predict drug behavior, optimize dosing, assess drug–drug interactions, support special populations, and obtain regulatory waivers in lieu of some clinical studies.[1][3][6]
- Modalities
- Small moleculeBiologicMonoclonal antibodyProteinVaccine
- Industry
- Drug Discovery Services
02
Partnerships
Simcyp Consortium of 30+–37 leading global pharmaceutical companies guiding platform development[1][3][6][8]Collaborations with multiple global regulatory agencies (e.g., FDA, EMA, PMDA) using and licensing Simcyp for regulatory submissions[1][2][3][7]
Beyond the preview
Go deeper on Simcyp.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Simcyp.